You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海吉亞醫療(06078.HK)擬以不超6.42億元收購賀州廣濟醫院99%股權
格隆匯 05-26 22:50

格隆匯5月26日丨海吉亞醫療(06078.HK)宣佈,於2021年5月26日,買方(伽瑪星科技及海吉亞醫院管理,均為公司附屬公司)、賣方及賀州廣濟醫院有限公司(作為目標醫院)。訂立股權轉讓協議,據此,買方有條件同意購買而賣方有條件同意出售目標醫院合共99%股權。最高代價為人民幣6.42億元,須以現金支付,惟可根據股權轉讓協議的條款予以調整。

截至公吿日期,賣方直接持有目標醫院99%股權,而目標醫院餘下1%股權由另一第三方持有。於完成後,目標醫院將成為公司的間接非全資附屬公司,且目標醫院的財務業績將綜合入賬至集團財務報表。

根據股權轉讓協議,買方、目標醫院及向上投資將按與現有合約安排大致相同的條款及條件就完成後由海吉亞醫院管理持有的目標醫院29%的股權訂立新合約安排,這將使公司能夠控制目標醫院29%的股權並取得由此產生的經濟利益。

為支付部分代價,於2021年5月26日,伽瑪星科技(作為借款方)與屬於獨立第三方的一家銀行(作為貸款方)訂立貸款協議,銀行提供本金總額最多為人民幣2.72億元的貸款。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account